Digital therapeutics (DTx) are becoming more prominent offerings in healthcare. Questions are now arising around which stakeholders will pay for these products and how accessible they’ll be for patients.

The number of mobile apps for health condition management is rising. This report examines how smartphone apps can help users control diseases and what gaps need to be filled before more consumers, providers, and payers get on board.

The remote patient monitoring market is surging, with the number of US users doubling between 2020 and 2025. Consumers, healthcare providers, payers, and pharma companies are all investing in the technology and programs to improve care and lower cost.

B2B tech products and services, the largest sector of B2B advertising, saw a massive boost in the US as the pandemic increased demand across the tech industry.

Pharma companies are finding it difficult to hire data science talent—we think it’ll make AI drug discovery startups like Valo (who is going public via a $2.8B SPAC merger) attractive partners.

Digital therapeutics (DTx) were gaining popularity as tools to help slash the US’ $3 trillion annual spending on chronic disease, and the pandemic has vaulted digital therapies into the spotlight. Now, the Teladoc-Livongo megamerger is heating up competition in the DTx space as players race to capture a slice of a market slated to reach $56 billion by 2025.

eMarketer analysts discuss our digital ad spend by industry forecasts, exploring verticals such as automotive, CPG, financial services, healthcare and pharmaceutical, travel and retail.

Digital ad spending in Germany will approach €7.3 billion ($8.6 billion) this year—nearly 10% more than in 2018. The sectors we analyze—including automotive, consumer packaged goods (CPG), financial services, healthcare/pharma, retail and travel—will all see much higher spending on mobile ads.

Voice-activated technology is in the early stages of development, but it has the potential to change the way healthcare brands, providers and patients interact—eventually making the healthcare system more efficient and effective.